Displaying drugs 2451 - 2475 of 2778 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Zafirlukast | 575.675 C31H33N3O6S |  | A leukotriene receptor antagonist used for prophylaxis and chronic treatment of asthma. | Anti-Asthmatic Agents / Leukotriene Antagonists |
| Dexamethasone metasulfobenzoate | 576.63 C29H33FO9S |  | An ophthalmic and auricular corticosteroid used with antibiotics for the treatment of otitis externa, blepharitis, and other inflammatory eye conditions. | Adrenal Cortex Hormones / Corticosteroids / Fused-Ring Compounds / Pregnadienes / Pregnadienetriols / Pregnanes / Steroids / Steroids, Fluorinated |
| Dihydro-alpha-ergocryptine | 577.726 C32H43N5O5 |  | A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. | Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates |
| Epicriptine | 577.726 C32H43N5O5 |  | A nootropic with an unknown mechanism of action indicated in individuals over sixty who manifest signs and symptoms of an idiopathic decline in mental capacity. | Alkaloids / Dopamine Agonists |
| Netupitant | 578.603 C30H32F6N4O |  | An antiemetic agent used in combination with palonosetron to prevent acute and delayed vomiting and nausea caused by chemotherapy. | Substance P/Neurokinin-1 Receptor Antagonist |
| Deserpidine | 578.6527 C32H38N2O8 |  | An alkaloid that has been used to manage hypertension. | Secologanin Tryptamine Alkaloids |
| Danicopan | 580.418 C26H23BrFN7O3 |  | A small molecule complement factor D inhibitor used to treat extravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria. | Amines / Amino Acids / Amino Acids, Cyclic / Amino Acids, Peptides, and Proteins / BCRP/ABCG2 Inhibitors / Complement Inactivating Agents / Heterocyclic Compounds, Fused-Ring / Imino Acids / P-glycoprotein inhibitors / Pyrazoles / Pyridines |
| Fostamatinib | 580.4595 C23H26FN6O9P |  | A spleen tyrosine kinase inhibitor used to treat chronic immune thrombocytopenia after attempting one other treatment. | Amines / BCRP/ABCG2 Inhibitors / Blood and Blood Forming Organs / Cytochrome P-450 CYP3A Inhibitors / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inhibitors / Cytochrome P-450 CYP3A4 Inhibitors (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Experimental Unapproved Treatments for COVID-19 / Hemostatics / Kinase Inhibitor / Oxazines / Phosphodiesterase 5 Inhibitors / Pyridines / Tyrosine Kinase Inhibitors / UGT1A1 Inhibitors / UGT1A9 Substrates / Vasodilating Agents |
| Lapatinib | 581.058 C29H26ClFN4O4S |  | An antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-positive breast cancer in patients who received prior chemotherapeutic treatments. | Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors / Protein Kinase Inhibitors |
| Streptomycin | 581.5741 C21H39N7O12 |  | An aminoglycoside antibiotic indicated to treat multi-drug resistant mycobacterium tuberculosis and various non-tuberculosis infections. | Streptomycins |
| Avacopan | 581.656 C33H35F4N3O2 |  | An orally bioavailable complement 5a receptor (C5aR) antagonist for the treatment of severe anti-neutrophil cytoplasmic (auto)antibody (ANCA)-associated vasculitis. | Selective Immunosuppressants |
| Ergotamine | 581.6615 C33H35N5O5 |  | An alpha-1 selective adrenergic agonist vasoconstrictor used to treat migraines with or without aura and cluster headaches. | Ergot Alkaloids and Derivatives |
| Polidocanol | 582.8073 C30H62O10 |  | A sclerosing agent used for the treatment of uncomplicated spider veins and uncomplicated reticular veins, all less than 3 mm in diameter, in the lower extremity. | Sclerosing Agents for Local Injection |
| Ivosidenib | 582.97 C28H22ClF3N6O3 |  | An isocitrate dehydrogenase-1 inhibitor used to treat acute myeloid leukemia and cholangiocarcinoma in adults with a susceptible IDH1 mutation. | Enzyme Inhibitors |
| Fostemsavir | 583.498 C25H26N7O8P |  | An antiretroviral HIV-1 attachment inhibitor targeted against the gp120 subunit within the HIV-1 gp160 envelope glycoprotein. | Anti-HIV Agents / HIV Fusion Inhibitors |
| Dihydrostreptomycin | 583.596 C21H41N7O12 |  | Dihydrostreptomycin is an aminoglycoside antibiotic. In humans, the use of dihydrostreptomycin has been associated with ototoxicity. The FDA withdrew its approval for the use of all drug products containing dihydrostreptomycin... | Anti-Bacterial Agents |
| Dihydroergotamine | 583.6774 C33H37N5O5 |  | An ergot alkaloid used in the acute treatment of migraine headache and cluster headache. | Ergot Alkaloids and Derivatives |
| Brigatinib | 584.1 C29H39ClN7O2P |  | An anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase positive metastatic non small cell lung cancer. | Anaplastic lymphoma kinase (ALK) inhibitors / Protein Kinase Inhibitors |
| Ouabain | 584.6525 C29H44O12 |  | For the treatment of atrial fibrillation and flutter and heart failure | Strophanthus Glycosides |
| Amikacin | 585.6025 C22H43N5O13 |  | An aminoglycoside used to treat infections caused by more resistant strains of Gram negative bacteria and some Gram positive bacteria. | Aminoglycoside Antibacterials / Anti-Bacterial Agents |
| Fosamprenavir | 585.607 C25H36N3O9PS |  | An antiretroviral agent used for the treatment and postexposure prophylaxis of human immunodeficiency virus (HIV-1) infection. | Anti-HIV Agents / HIV Protease Inhibitors / Protease Inhibitors |
| Tigecycline | 585.6487 C29H39N5O8 |  | A glycylcycline antibiotic used to treat a number of susceptible bacterial infections. | Anti-Bacterial Agents / Protein Synthesis Inhibitors / Tetracyclines |
| Mobocertinib | 585.709 C32H39N7O4 |  | An oral kinase inhibitor targeted against EGFR and used in the treatment of NSCLC with EGFR exon 20 insertion mutations. | Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors / Tyrosine Kinase Inhibitors |
| Samarium (153Sm) lexidronam | 586.021 C6H17N2O12P4Sm |  | A chelated complex of samarium isotope and EDTMP that concentrates in areas with high bone turnover such as sites of metastases to relieve pain associated with osteoblastic metastatic bone lesions. | Various Pain Palliation Radiopharmaceuticals |
| Montelukast | 586.183 C35H36ClNO3S |  | A leukotriene receptor antagonist used as part of an asthma therapy regimen, to prevent exercise induced bronchoconstriction, and to treat seasonal allergic rhinitis. | Anti-Asthmatic Agents / Cytochrome P-450 CYP1A2 Inducers / Leukotriene Antagonists |
Displaying drugs 2451 - 2475 of 2778 in total